Amgen has announced a $900-million expansion of its facility in New Albany, Ohio. 

Amgen first announced plans to build the Ohio facility in June 2021, and last year (February 2024), the company opened the nearly 300,000-square-foot final product assembly and packaging plant. The company reported that the new facility created 400 new jobs.  

With its new $900-million facility expansion, the company will be adding 350 new jobs to bring the total to 750 with a total investment in Central Ohio of more than $1.4 billion. 

The Ohio expansion follows the company’s announcement last December (December 2024) of a $1-billion expansion to establish a second drug-substance manufacturing facility in Holly Springs, North Carolina. The company broke ground at the facility earlier this year (January 2025). That brought the company’s total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550-million commitment. In tandem with the existing facility, these investments will create 370 new jobs in the region, reported Amgen at the time of the announcement (December 5, 2024).  

Since 2017, Amgen reports that it has invested almost $5 billion in direct capital expenditures in the US.  

Source: Amgen and Amgen (annual filing).